[The future of pharmacogenetics--cost-effectiveness and barriers].
Gyrd-Hansen
Dorte
D
Syddansk Universitet, Institut for Sundhedstjenesteforskning, Enhed for Sundhedsøkonomi. dgh@sam.sdu.dk
D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics; D005820:Genetic Testing; D006801:Humans; D010597:Pharmacogenetics / Q000191:economics / Q000639:trends*; D013678:Technology, Pharmaceutical / Q000191:economics